The global Therapeutic Nuclear Medicines market is projected to grow from US$ 1997.4 million in 2024 to US$ 5392 million by 2030, at a Compound Annual Growth Rate (CAGR) of 18.0% during the forecast period.

Therapeutic Nuclear Medicines Market

Radioactive material, called radiopharmaceuticals, can be used to treat certain conditions. This is called nuclear medicine therapy.

Therapeutic nuclear medicines are a pharmaceutical formulation that consists of radioactive substances (radioisotopes). Therapeutic nuclear medicines are intending for the treatment of cancer, metastatic bone pain and other diseases. The radioactive material of therapeutic nuclear medicines is capable of killing the cancerous tissue, reducing the size of a tumor and reducing pain.

Global Therapeutic Nuclear Medicines key players include Bayer, Novartis AG, China Isotope & Radiation, etc. Global top three manufacturers hold a share over 75%.

North America is the largest market, with a share about 45%, followed by Europe and Asia-Pacific, both have a share about 50 percent.

In terms of product, Radium-223 is the largest segment, with a share over 45%. And in terms of application, the largest application is Thyroid, followed by Bone Metastasis.

Report Covers:

This report presents an overview of global market for Therapeutic Nuclear Medicines, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.

This report researches the key producers of Therapeutic Nuclear Medicines, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Therapeutic Nuclear Medicines, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Therapeutic Nuclear Medicines sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Therapeutic Nuclear Medicines market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type, and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Therapeutic Nuclear Medicines sales, projected growth trends, production technology, application and end-user industry.

Market Segmentation

Scope of Therapeutic Nuclear Medicines Market Report

Report Metric	Details
Report Name	Therapeutic Nuclear Medicines Market
Accounted market size in 2024	US$ 1997.4 million
Forecasted market size in 2030	US$ 5392 million
CAGR	18.0
Base Year	2024
Forecasted years	2024 - 2030
Segment by Type	Radium-223 Lutetium-177 Iodine-131 Other
Segment by Application	Thyroid Bone Metastasis Lymphoma Other
Segment by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	China Isotope & Radiation, Q BioMed, Curium Pharmaceuticals, Jubilant DraxImage, Dongcheng, Lantheus, Acrotech Biopharma., Progenics Pharmaceuticals, International Isotopes
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Therapeutic Nuclear Medicines in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Therapeutic Nuclear Medicines manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: China by Type, and by Application, sales, and revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Therapeutic Nuclear Medicines sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.

FAQ for this report

How fast is Therapeutic Nuclear Medicines Market growing?

Ans: The Therapeutic Nuclear Medicines Market witnessing a CAGR of 18.0 during the forecast period 2024-2030.

What is the Therapeutic Nuclear Medicines Market size in 2030?

Ans: The Therapeutic Nuclear Medicines Market size in 2030 will be US$ 5392 million.

What is the market share of major companies in Therapeutic Nuclear Medicines Market?

Ans: Global top three manufacturers hold a share over 75%.

What is the Therapeutic Nuclear Medicines Market share by type?

Ans: In terms of product, Radium-223 is the largest segment, with a share over 45%.

Who are the main players in the Therapeutic Nuclear Medicines Market report?

Ans: The main players in the Therapeutic Nuclear Medicines Market are China Isotope & Radiation, Q BioMed, Curium Pharmaceuticals, Jubilant DraxImage, Dongcheng, Lantheus, Acrotech Biopharma., Progenics Pharmaceuticals, International Isotopes

What are the Application segmentation covered in the Therapeutic Nuclear Medicines Market report?

Ans: The Applications covered in the Therapeutic Nuclear Medicines Market report are Thyroid, Bone Metastasis, Lymphoma, Other

What are the Type segmentation covered in the Therapeutic Nuclear Medicines Market report?

Ans: The Types covered in the Therapeutic Nuclear Medicines Market report are Radium-223, Lutetium-177, Iodine-131, Other

1 Study Coverage

1.1 Therapeutic Nuclear Medicines Product Introduction

1.2 Market by Type

1.2.1 Global Therapeutic Nuclear Medicines Market Size Growth Rate by Type, 2019 VS 2023 VS 2030

1.2.2 Radium-223

1.2.3 Lutetium-177

1.2.4 Iodine-131

1.2.5 Other

1.3 Market by Application

1.3.1 Global Therapeutic Nuclear Medicines Market Size Growth Rate by Application, 2019 VS 2023 VS 2030

1.3.2 Thyroid

1.3.3 Bone Metastasis

1.3.4 Lymphoma

1.3.5 Other

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Executive Summary

2.1 Global Therapeutic Nuclear Medicines Sales Estimates and Forecasts 2019-2030

2.2 Global Therapeutic Nuclear Medicines Revenue by Region

2.2.1 Global Therapeutic Nuclear Medicines Revenue by Region: 2019 VS 2023 VS 2030

2.2.2 Global Therapeutic Nuclear Medicines Revenue by Region (2019-2024)

2.2.3 Global Therapeutic Nuclear Medicines Revenue by Region (2025-2030)

2.2.4 Global Therapeutic Nuclear Medicines Revenue Market Share by Region (2019-2030)

2.3 Global Therapeutic Nuclear Medicines Sales Estimates and Forecasts 2019-2030

2.4 Global Therapeutic Nuclear Medicines Sales by Region

2.4.1 Global Therapeutic Nuclear Medicines Sales by Region: 2019 VS 2023 VS 2030

2.4.2 Global Therapeutic Nuclear Medicines Sales by Region (2019-2024)

2.4.3 Global Therapeutic Nuclear Medicines Sales by Region (2025-2030)

2.4.4 Global Therapeutic Nuclear Medicines Sales Market Share by Region (2019-2030)

2.5 US & Canada

2.6 Europe

2.7 China

2.8 Asia (excluding China)

2.9 Middle East, Africa and Latin America

3 Competition by Manufactures

3.1 Global Therapeutic Nuclear Medicines Sales by Manufacturers

3.1.1 Global Therapeutic Nuclear Medicines Sales by Manufacturers (2019-2024)

3.1.2 Global Therapeutic Nuclear Medicines Sales Market Share by Manufacturers (2019-2024)

3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Therapeutic Nuclear Medicines in 2023

3.2 Global Therapeutic Nuclear Medicines Revenue by Manufacturers

3.2.1 Global Therapeutic Nuclear Medicines Revenue by Manufacturers (2019-2024)

3.2.2 Global Therapeutic Nuclear Medicines Revenue Market Share by Manufacturers (2019-2024)

3.2.3 Global Top 10 and Top 5 Companies by Therapeutic Nuclear Medicines Revenue in 2023

3.3 Global Key Players of Therapeutic Nuclear Medicines, Industry Ranking, 2022 VS 2023 VS 2024

3.4 Global Therapeutic Nuclear Medicines Sales Price by Manufacturers

3.5 Analysis of Competitive Landscape

3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)

3.5.2 Global Therapeutic Nuclear Medicines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.6 Global Key Manufacturers of Therapeutic Nuclear Medicines, Manufacturing Base Distribution and Headquarters

3.7 Global Key Manufacturers of Therapeutic Nuclear Medicines, Product Offered and Application

3.8 Global Key Manufacturers of Therapeutic Nuclear Medicines, Date of Enter into This Industry

3.9 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

4.1 Global Therapeutic Nuclear Medicines Sales by Type

4.1.1 Global Therapeutic Nuclear Medicines Historical Sales by Type (2019-2024)

4.1.2 Global Therapeutic Nuclear Medicines Forecasted Sales by Type (2025-2030)

4.1.3 Global Therapeutic Nuclear Medicines Sales Market Share by Type (2019-2030)

4.2 Global Therapeutic Nuclear Medicines Revenue by Type

4.2.1 Global Therapeutic Nuclear Medicines Historical Revenue by Type (2019-2024)

4.2.2 Global Therapeutic Nuclear Medicines Forecasted Revenue by Type (2025-2030)

4.2.3 Global Therapeutic Nuclear Medicines Revenue Market Share by Type (2019-2030)

4.3 Global Therapeutic Nuclear Medicines Price by Type

4.3.1 Global Therapeutic Nuclear Medicines Price by Type (2019-2024)

4.3.2 Global Therapeutic Nuclear Medicines Price Forecast by Type (2025-2030)

5 Market Size by Application

5.1 Global Therapeutic Nuclear Medicines Sales by Application

5.1.1 Global Therapeutic Nuclear Medicines Historical Sales by Application (2019-2024)

5.1.2 Global Therapeutic Nuclear Medicines Forecasted Sales by Application (2025-2030)

5.1.3 Global Therapeutic Nuclear Medicines Sales Market Share by Application (2019-2030)

5.2 Global Therapeutic Nuclear Medicines Revenue by Application

5.2.1 Global Therapeutic Nuclear Medicines Historical Revenue by Application (2019-2024)

5.2.2 Global Therapeutic Nuclear Medicines Forecasted Revenue by Application (2025-2030)

5.2.3 Global Therapeutic Nuclear Medicines Revenue Market Share by Application (2019-2030)

5.3 Global Therapeutic Nuclear Medicines Price by Application

5.3.1 Global Therapeutic Nuclear Medicines Price by Application (2019-2024)

5.3.2 Global Therapeutic Nuclear Medicines Price Forecast by Application (2025-2030)

6 US & Canada

6.1 US & Canada Therapeutic Nuclear Medicines Market Size by Type

6.1.1 US & Canada Therapeutic Nuclear Medicines Sales by Type (2019-2030)

6.1.2 US & Canada Therapeutic Nuclear Medicines Revenue by Type (2019-2030)

6.2 US & Canada Therapeutic Nuclear Medicines Market Size by Application

6.2.1 US & Canada Therapeutic Nuclear Medicines Sales by Application (2019-2030)

6.2.2 US & Canada Therapeutic Nuclear Medicines Revenue by Application (2019-2030)

6.3 US & Canada Therapeutic Nuclear Medicines Market Size by Country

6.3.1 US & Canada Therapeutic Nuclear Medicines Revenue by Country: 2019 VS 2023 VS 2030

6.3.2 US & Canada Therapeutic Nuclear Medicines Sales by Country (2019-2030)

6.3.3 US & Canada Therapeutic Nuclear Medicines Revenue by Country (2019-2030)

6.3.4 US

6.3.5 Canada

7 Europe

7.1 Europe Therapeutic Nuclear Medicines Market Size by Type

7.1.1 Europe Therapeutic Nuclear Medicines Sales by Type (2019-2030)

7.1.2 Europe Therapeutic Nuclear Medicines Revenue by Type (2019-2030)

7.2 Europe Therapeutic Nuclear Medicines Market Size by Application

7.2.1 Europe Therapeutic Nuclear Medicines Sales by Application (2019-2030)

7.2.2 Europe Therapeutic Nuclear Medicines Revenue by Application (2019-2030)

7.3 Europe Therapeutic Nuclear Medicines Market Size by Country

7.3.1 Europe Therapeutic Nuclear Medicines Revenue by Country: 2019 VS 2023 VS 2030

7.3.2 Europe Therapeutic Nuclear Medicines Sales by Country (2019-2030)

7.3.3 Europe Therapeutic Nuclear Medicines Revenue by Country (2019-2030)

7.3.4 Germany

7.3.5 France

7.3.6 U.K.

7.3.7 Italy

7.3.8 Russia

8 China

8.1 China Therapeutic Nuclear Medicines Market Size

8.1.1 China Therapeutic Nuclear Medicines Sales (2019-2030)

8.1.2 China Therapeutic Nuclear Medicines Revenue (2019-2030)

8.2 China Therapeutic Nuclear Medicines Market Size by Application

8.2.1 China Therapeutic Nuclear Medicines Sales by Application (2019-2030)

8.2.2 China Therapeutic Nuclear Medicines Revenue by Application (2019-2030)

9 Asia (excluding China)

9.1 Asia Therapeutic Nuclear Medicines Market Size by Type

9.1.1 Asia Therapeutic Nuclear Medicines Sales by Type (2019-2030)

9.1.2 Asia Therapeutic Nuclear Medicines Revenue by Type (2019-2030)

9.2 Asia Therapeutic Nuclear Medicines Market Size by Application

9.2.1 Asia Therapeutic Nuclear Medicines Sales by Application (2019-2030)

9.2.2 Asia Therapeutic Nuclear Medicines Revenue by Application (2019-2030)

9.3 Asia Therapeutic Nuclear Medicines Sales by Region

9.3.1 Asia Therapeutic Nuclear Medicines Revenue by Region: 2019 VS 2023 VS 2030

9.3.2 Asia Therapeutic Nuclear Medicines Revenue by Region (2019-2030)

9.3.3 Asia Therapeutic Nuclear Medicines Sales by Region (2019-2030)

9.3.4 Japan

9.3.5 South Korea

9.3.6 China Taiwan

9.3.7 Southeast Asia

9.3.8 India

10 Middle East, Africa and Latin America

10.1 Middle East, Africa and Latin America Therapeutic Nuclear Medicines Market Size by Type

10.1.1 Middle East, Africa and Latin America Therapeutic Nuclear Medicines Sales by Type (2019-2030)

10.1.2 Middle East, Africa and Latin America Therapeutic Nuclear Medicines Revenue by Type (2019-2030)

10.2 Middle East, Africa and Latin America Therapeutic Nuclear Medicines Market Size by Application

10.2.1 Middle East, Africa and Latin America Therapeutic Nuclear Medicines Sales by Application (2019-2030)

10.2.2 Middle East, Africa and Latin America Therapeutic Nuclear Medicines Revenue by Application (2019-2030)

10.3 Middle East, Africa and Latin America Therapeutic Nuclear Medicines Sales by Country

10.3.1 Middle East, Africa and Latin America Therapeutic Nuclear Medicines Revenue by Country: 2019 VS 2023 VS 2030

10.3.2 Middle East, Africa and Latin America Therapeutic Nuclear Medicines Revenue by Country (2019-2030)

10.3.3 Middle East, Africa and Latin America Therapeutic Nuclear Medicines Sales by Country (2019-2030)

10.3.4 Brazil

10.3.5 Mexico

10.3.6 Turkey

10.3.7 Israel

10.3.8 GCC Countries

11 Company Profiles

11.1 Novartis AG

11.1.1 Novartis AG Company Information

11.1.2 Novartis AG Overview

11.1.3 Novartis AG Therapeutic Nuclear Medicines Sales, Price, Revenue and Gross Margin (2019-2024)

11.1.4 Novartis AG Therapeutic Nuclear Medicines Product Model Numbers, Pictures, Descriptions and Specifications

11.1.5 Novartis AG Recent Developments

11.2 Bayer

11.2.1 Bayer Company Information

11.2.2 Bayer Overview

11.2.3 Bayer Therapeutic Nuclear Medicines Sales, Price, Revenue and Gross Margin (2019-2024)

11.2.4 Bayer Therapeutic Nuclear Medicines Product Model Numbers, Pictures, Descriptions and Specifications

11.2.5 Bayer Recent Developments

11.3 China Isotope & Radiation

11.3.1 China Isotope & Radiation Company Information

11.3.2 China Isotope & Radiation Overview

11.3.3 China Isotope & Radiation Therapeutic Nuclear Medicines Sales, Price, Revenue and Gross Margin (2019-2024)

11.3.4 China Isotope & Radiation Therapeutic Nuclear Medicines Product Model Numbers, Pictures, Descriptions and Specifications

11.3.5 China Isotope & Radiation Recent Developments

11.4 Q BioMed

11.4.1 Q BioMed Company Information

11.4.2 Q BioMed Overview

11.4.3 Q BioMed Therapeutic Nuclear Medicines Sales, Price, Revenue and Gross Margin (2019-2024)

11.4.4 Q BioMed Therapeutic Nuclear Medicines Product Model Numbers, Pictures, Descriptions and Specifications

11.4.5 Q BioMed Recent Developments

11.5 Curium Pharmaceuticals

11.5.1 Curium Pharmaceuticals Company Information

11.5.2 Curium Pharmaceuticals Overview

11.5.3 Curium Pharmaceuticals Therapeutic Nuclear Medicines Sales, Price, Revenue and Gross Margin (2019-2024)

11.5.4 Curium Pharmaceuticals Therapeutic Nuclear Medicines Product Model Numbers, Pictures, Descriptions and Specifications

11.5.5 Curium Pharmaceuticals Recent Developments

11.6 Jubilant DraxImage

11.6.1 Jubilant DraxImage Company Information

11.6.2 Jubilant DraxImage Overview

11.6.3 Jubilant DraxImage Therapeutic Nuclear Medicines Sales, Price, Revenue and Gross Margin (2019-2024)

11.6.4 Jubilant DraxImage Therapeutic Nuclear Medicines Product Model Numbers, Pictures, Descriptions and Specifications

11.6.5 Jubilant DraxImage Recent Developments

11.7 Dongcheng

11.7.1 Dongcheng Company Information

11.7.2 Dongcheng Overview

11.7.3 Dongcheng Therapeutic Nuclear Medicines Sales, Price, Revenue and Gross Margin (2019-2024)

11.7.4 Dongcheng Therapeutic Nuclear Medicines Product Model Numbers, Pictures, Descriptions and Specifications

11.7.5 Dongcheng Recent Developments

11.8 Lantheus

11.8.1 Lantheus Company Information

11.8.2 Lantheus Overview

11.8.3 Lantheus Therapeutic Nuclear Medicines Sales, Price, Revenue and Gross Margin (2019-2024)

11.8.4 Lantheus Therapeutic Nuclear Medicines Product Model Numbers, Pictures, Descriptions and Specifications

11.8.5 Lantheus Recent Developments

11.9 Acrotech Biopharma.

11.9.1 Acrotech Biopharma. Company Information

11.9.2 Acrotech Biopharma. Overview

11.9.3 Acrotech Biopharma. Therapeutic Nuclear Medicines Sales, Price, Revenue and Gross Margin (2019-2024)

11.9.4 Acrotech Biopharma. Therapeutic Nuclear Medicines Product Model Numbers, Pictures, Descriptions and Specifications

11.9.5 Acrotech Biopharma. Recent Developments

11.10 Progenics Pharmaceuticals

11.10.1 Progenics Pharmaceuticals Company Information

11.10.2 Progenics Pharmaceuticals Overview

11.10.3 Progenics Pharmaceuticals Therapeutic Nuclear Medicines Sales, Price, Revenue and Gross Margin (2019-2024)

11.10.4 Progenics Pharmaceuticals Therapeutic Nuclear Medicines Product Model Numbers, Pictures, Descriptions and Specifications

11.10.5 Progenics Pharmaceuticals Recent Developments

11.11 International Isotopes

11.11.1 International Isotopes Company Information

11.11.2 International Isotopes Overview

11.11.3 International Isotopes Therapeutic Nuclear Medicines Sales, Price, Revenue and Gross Margin (2019-2024)

11.11.4 International Isotopes Therapeutic Nuclear Medicines Product Model Numbers, Pictures, Descriptions and Specifications

11.11.5 International Isotopes Recent Developments

12 Industry Chain and Sales Channels Analysis

12.1 Therapeutic Nuclear Medicines Industry Chain Analysis

12.2 Therapeutic Nuclear Medicines Key Raw Materials

12.2.1 Key Raw Materials

12.2.2 Raw Materials Key Suppliers

12.3 Therapeutic Nuclear Medicines Production Mode & Process

12.4 Therapeutic Nuclear Medicines Sales and Marketing

12.4.1 Therapeutic Nuclear Medicines Sales Channels

12.4.2 Therapeutic Nuclear Medicines Distributors

12.5 Therapeutic Nuclear Medicines Customers

13 Market Dynamics

13.1 Therapeutic Nuclear Medicines Industry Trends

13.2 Therapeutic Nuclear Medicines Market Drivers

13.3 Therapeutic Nuclear Medicines Market Challenges

13.4 Therapeutic Nuclear Medicines Market Restraints

14 Key Findings in The Global Therapeutic Nuclear Medicines Study

15 Appendix

15.1 Research Methodology

15.1.1 Methodology/Research Approach

15.1.2 Data Source

15.2 Author Details

15.3 Disclaimer

FEATURED COMPANIES

Novartis

Bayer

China Isotope & Radiation

Q BioMed

Curium Pharmaceuticals

Progenics Pharmaceuticals

International Isotopes

List of Tables

Table 1. Global Therapeutic Nuclear Medicines Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)

Table 2. Major Manufacturers of Radium-223

Table 3. Major Manufacturers of Lutetium-177

Table 4. Major Manufacturers of Iodine-131

Table 5. Major Manufacturers of Other

Table 6. Global Therapeutic Nuclear Medicines Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)

Table 7. Global Therapeutic Nuclear Medicines Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 8. Global Therapeutic Nuclear Medicines Revenue by Region (2019-2024) & (US$ Million)

Table 9. Global Therapeutic Nuclear Medicines Revenue by Region (2025-2030) & (US$ Million)

Table 10. Global Therapeutic Nuclear Medicines Revenue Market Share by Region (2019-2024)

Table 11. Global Therapeutic Nuclear Medicines Revenue Market Share by Region (2025-2030)

Table 12. Global Therapeutic Nuclear Medicines Sales Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 13. Global Therapeutic Nuclear Medicines Sales by Region (2019-2024) & (K Units)

Table 14. Global Therapeutic Nuclear Medicines Sales by Region (2025-2030) & (K Units)

Table 15. Global Therapeutic Nuclear Medicines Sales Market Share by Region (2019-2024)

Table 16. Global Therapeutic Nuclear Medicines Sales Market Share by Region (2025-2030)

Table 17. Global Therapeutic Nuclear Medicines Sales by Manufacturers (2019-2024) & (K Units)

Table 18. Global Therapeutic Nuclear Medicines Sales Share by Manufacturers (2019-2024)

Table 19. Global Therapeutic Nuclear Medicines Revenue by Manufacturers (2019-2024) & (US$ Million)

Table 20. Global Therapeutic Nuclear Medicines Revenue Share by Manufacturers (2019-2024)

Table 21. Global Key Players of Therapeutic Nuclear Medicines, Industry Ranking, 2022 VS 2023 VS 2024

Table 22. Therapeutic Nuclear Medicines Price by Manufacturers 2019-2024 (USD/Unit)

Table 23. Global Therapeutic Nuclear Medicines Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 24. Global Therapeutic Nuclear Medicines by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Therapeutic Nuclear Medicines as of 2023)

Table 25. Global Key Manufacturers of Therapeutic Nuclear Medicines, Manufacturing Base Distribution and Headquarters

Table 26. Global Key Manufacturers of Therapeutic Nuclear Medicines, Product Offered and Application

Table 27. Global Key Manufacturers of Therapeutic Nuclear Medicines, Date of Enter into This Industry

Table 28. Mergers & Acquisitions, Expansion Plans

Table 29. Global Therapeutic Nuclear Medicines Sales by Type (2019-2024) & (K Units)

Table 30. Global Therapeutic Nuclear Medicines Sales by Type (2025-2030) & (K Units)

Table 31. Global Therapeutic Nuclear Medicines Sales Share by Type (2019-2024)

Table 32. Global Therapeutic Nuclear Medicines Sales Share by Type (2025-2030)

Table 33. Global Therapeutic Nuclear Medicines Revenue by Type (2019-2024) & (US$ Million)

Table 34. Global Therapeutic Nuclear Medicines Revenue by Type (2025-2030) & (US$ Million)

Table 35. Global Therapeutic Nuclear Medicines Revenue Share by Type (2019-2024)

Table 36. Global Therapeutic Nuclear Medicines Revenue Share by Type (2025-2030)

Table 37. Therapeutic Nuclear Medicines Price by Type (2019-2024) & (USD/Unit)

Table 38. Global Therapeutic Nuclear Medicines Price Forecast by Type (2025-2030) & (USD/Unit)

Table 39. Global Therapeutic Nuclear Medicines Sales by Application (2019-2024) & (K Units)

Table 40. Global Therapeutic Nuclear Medicines Sales by Application (2025-2030) & (K Units)

Table 41. Global Therapeutic Nuclear Medicines Sales Share by Application (2019-2024)

Table 42. Global Therapeutic Nuclear Medicines Sales Share by Application (2025-2030)

Table 43. Global Therapeutic Nuclear Medicines Revenue by Application (2019-2024) & (US$ Million)

Table 44. Global Therapeutic Nuclear Medicines Revenue by Application (2025-2030) & (US$ Million)

Table 45. Global Therapeutic Nuclear Medicines Revenue Share by Application (2019-2024)

Table 46. Global Therapeutic Nuclear Medicines Revenue Share by Application (2025-2030)

Table 47. Therapeutic Nuclear Medicines Price by Application (2019-2024) & (USD/Unit)

Table 48. Global Therapeutic Nuclear Medicines Price Forecast by Application (2025-2030) & (USD/Unit)

Table 49. US & Canada Therapeutic Nuclear Medicines Sales by Type (2019-2024) & (K Units)

Table 50. US & Canada Therapeutic Nuclear Medicines Sales by Type (2025-2030) & (K Units)

Table 51. US & Canada Therapeutic Nuclear Medicines Revenue by Type (2019-2024) & (US$ Million)

Table 52. US & Canada Therapeutic Nuclear Medicines Revenue by Type (2025-2030) & (US$ Million)

Table 53. US & Canada Therapeutic Nuclear Medicines Sales by Application (2019-2024) & (K Units)

Table 54. US & Canada Therapeutic Nuclear Medicines Sales by Application (2025-2030) & (K Units)

Table 55. US & Canada Therapeutic Nuclear Medicines Revenue by Application (2019-2024) & (US$ Million)

Table 56. US & Canada Therapeutic Nuclear Medicines Revenue by Application (2025-2030) & (US$ Million)

Table 57. US & Canada Therapeutic Nuclear Medicines Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 58. US & Canada Therapeutic Nuclear Medicines Revenue by Country (2019-2024) & (US$ Million)

Table 59. US & Canada Therapeutic Nuclear Medicines Revenue by Country (2025-2030) & (US$ Million)

Table 60. US & Canada Therapeutic Nuclear Medicines Sales by Country (2019-2024) & (K Units)

Table 61. US & Canada Therapeutic Nuclear Medicines Sales by Country (2025-2030) & (K Units)

Table 62. Europe Therapeutic Nuclear Medicines Sales by Type (2019-2024) & (K Units)

Table 63. Europe Therapeutic Nuclear Medicines Sales by Type (2025-2030) & (K Units)

Table 64. Europe Therapeutic Nuclear Medicines Revenue by Type (2019-2024) & (US$ Million)

Table 65. Europe Therapeutic Nuclear Medicines Revenue by Type (2025-2030) & (US$ Million)

Table 66. Europe Therapeutic Nuclear Medicines Sales by Application (2019-2024) & (K Units)

Table 67. Europe Therapeutic Nuclear Medicines Sales by Application (2025-2030) & (K Units)

Table 68. Europe Therapeutic Nuclear Medicines Revenue by Application (2019-2024) & (US$ Million)

Table 69. Europe Therapeutic Nuclear Medicines Revenue by Application (2025-2030) & (US$ Million)

Table 70. Europe Therapeutic Nuclear Medicines Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 71. Europe Therapeutic Nuclear Medicines Revenue by Country (2019-2024) & (US$ Million)

Table 72. Europe Therapeutic Nuclear Medicines Revenue by Country (2025-2030) & (US$ Million)

Table 73. Europe Therapeutic Nuclear Medicines Sales by Country (2019-2024) & (K Units)

Table 74. Europe Therapeutic Nuclear Medicines Sales by Country (2025-2030) & (K Units)

Table 75. China Therapeutic Nuclear Medicines Sales by Type (2019-2024) & (K Units)

Table 76. China Therapeutic Nuclear Medicines Sales by Type (2025-2030) & (K Units)

Table 77. China Therapeutic Nuclear Medicines Revenue by Type (2019-2024) & (US$ Million)

Table 78. China Therapeutic Nuclear Medicines Revenue by Type (2025-2030) & (US$ Million)

Table 79. China Therapeutic Nuclear Medicines Sales by Application (2019-2024) & (K Units)

Table 80. China Therapeutic Nuclear Medicines Sales by Application (2025-2030) & (K Units)

Table 81. China Therapeutic Nuclear Medicines Revenue by Application (2019-2024) & (US$ Million)

Table 82. China Therapeutic Nuclear Medicines Revenue by Application (2025-2030) & (US$ Million)

Table 83. Asia Therapeutic Nuclear Medicines Sales by Type (2019-2024) & (K Units)

Table 84. Asia Therapeutic Nuclear Medicines Sales by Type (2025-2030) & (K Units)

Table 85. Asia Therapeutic Nuclear Medicines Revenue by Type (2019-2024) & (US$ Million)

Table 86. Asia Therapeutic Nuclear Medicines Revenue by Type (2025-2030) & (US$ Million)

Table 87. Asia Therapeutic Nuclear Medicines Sales by Application (2019-2024) & (K Units)

Table 88. Asia Therapeutic Nuclear Medicines Sales by Application (2025-2030) & (K Units)

Table 89. Asia Therapeutic Nuclear Medicines Revenue by Application (2019-2024) & (US$ Million)

Table 90. Asia Therapeutic Nuclear Medicines Revenue by Application (2025-2030) & (US$ Million)

Table 91. Asia Therapeutic Nuclear Medicines Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 92. Asia Therapeutic Nuclear Medicines Revenue by Region (2019-2024) & (US$ Million)

Table 93. Asia Therapeutic Nuclear Medicines Revenue by Region (2025-2030) & (US$ Million)

Table 94. Asia Therapeutic Nuclear Medicines Sales by Region (2019-2024) & (K Units)

Table 95. Asia Therapeutic Nuclear Medicines Sales by Region (2025-2030) & (K Units)

Table 96. Middle East, Africa and Latin America Therapeutic Nuclear Medicines Sales by Type (2019-2024) & (K Units)

Table 97. Middle East, Africa and Latin America Therapeutic Nuclear Medicines Sales by Type (2025-2030) & (K Units)

Table 98. Middle East, Africa and Latin America Therapeutic Nuclear Medicines Revenue by Type (2019-2024) & (US$ Million)

Table 99. Middle East, Africa and Latin America Therapeutic Nuclear Medicines Revenue by Type (2025-2030) & (US$ Million)

Table 100. Middle East, Africa and Latin America Therapeutic Nuclear Medicines Sales by Application (2019-2024) & (K Units)

Table 101. Middle East, Africa and Latin America Therapeutic Nuclear Medicines Sales by Application (2025-2030) & (K Units)

Table 102. Middle East, Africa and Latin America Therapeutic Nuclear Medicines Revenue by Application (2019-2024) & (US$ Million)

Table 103. Middle East, Africa and Latin America Therapeutic Nuclear Medicines Revenue by Application (2025-2030) & (US$ Million)

Table 104. Middle East, Africa and Latin America Therapeutic Nuclear Medicines Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 105. Middle East, Africa and Latin America Therapeutic Nuclear Medicines Revenue by Country (2019-2024) & (US$ Million)

Table 106. Middle East, Africa and Latin America Therapeutic Nuclear Medicines Revenue by Country (2025-2030) & (US$ Million)

Table 107. Middle East, Africa and Latin America Therapeutic Nuclear Medicines Sales by Country (2019-2024) & (K Units)

Table 108. Middle East, Africa and Latin America Therapeutic Nuclear Medicines Sales by Country (2025-2030) & (K Units)

Table 109. Novartis AG Company Information

Table 110. Novartis AG Description and Major Businesses

Table 111. Novartis AG Therapeutic Nuclear Medicines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 112. Novartis AG Therapeutic Nuclear Medicines Product Model Numbers, Pictures, Descriptions and Specifications

Table 113. Novartis AG Recent Developments

Table 114. Bayer Company Information

Table 115. Bayer Description and Major Businesses

Table 116. Bayer Therapeutic Nuclear Medicines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 117. Bayer Therapeutic Nuclear Medicines Product Model Numbers, Pictures, Descriptions and Specifications

Table 118. Bayer Recent Developments

Table 119. China Isotope & Radiation Company Information

Table 120. China Isotope & Radiation Description and Major Businesses

Table 121. China Isotope & Radiation Therapeutic Nuclear Medicines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 122. China Isotope & Radiation Therapeutic Nuclear Medicines Product Model Numbers, Pictures, Descriptions and Specifications

Table 123. China Isotope & Radiation Recent Developments

Table 124. Q BioMed Company Information

Table 125. Q BioMed Description and Major Businesses

Table 126. Q BioMed Therapeutic Nuclear Medicines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 127. Q BioMed Therapeutic Nuclear Medicines Product Model Numbers, Pictures, Descriptions and Specifications

Table 128. Q BioMed Recent Developments

Table 129. Curium Pharmaceuticals Company Information

Table 130. Curium Pharmaceuticals Description and Major Businesses

Table 131. Curium Pharmaceuticals Therapeutic Nuclear Medicines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 132. Curium Pharmaceuticals Therapeutic Nuclear Medicines Product Model Numbers, Pictures, Descriptions and Specifications

Table 133. Curium Pharmaceuticals Recent Developments

Table 134. Jubilant DraxImage Company Information

Table 135. Jubilant DraxImage Description and Major Businesses

Table 136. Jubilant DraxImage Therapeutic Nuclear Medicines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 137. Jubilant DraxImage Therapeutic Nuclear Medicines Product Model Numbers, Pictures, Descriptions and Specifications

Table 138. Jubilant DraxImage Recent Developments

Table 139. Dongcheng Company Information

Table 140. Dongcheng Description and Major Businesses

Table 141. Dongcheng Therapeutic Nuclear Medicines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 142. Dongcheng Therapeutic Nuclear Medicines Product Model Numbers, Pictures, Descriptions and Specifications

Table 143. Dongcheng Recent Developments

Table 144. Lantheus Company Information

Table 145. Lantheus Description and Major Businesses

Table 146. Lantheus Therapeutic Nuclear Medicines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 147. Lantheus Therapeutic Nuclear Medicines Product Model Numbers, Pictures, Descriptions and Specifications

Table 148. Lantheus Recent Developments

Table 149. Acrotech Biopharma. Company Information

Table 150. Acrotech Biopharma. Description and Major Businesses

Table 151. Acrotech Biopharma. Therapeutic Nuclear Medicines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 152. Acrotech Biopharma. Therapeutic Nuclear Medicines Product Model Numbers, Pictures, Descriptions and Specifications

Table 153. Acrotech Biopharma. Recent Developments

Table 154. Progenics Pharmaceuticals Company Information

Table 155. Progenics Pharmaceuticals Description and Major Businesses

Table 156. Progenics Pharmaceuticals Therapeutic Nuclear Medicines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 157. Progenics Pharmaceuticals Therapeutic Nuclear Medicines Product Model Numbers, Pictures, Descriptions and Specifications

Table 158. Progenics Pharmaceuticals Recent Developments

Table 159. International Isotopes Company Information

Table 160. International Isotopes Description and Major Businesses

Table 161. International Isotopes Therapeutic Nuclear Medicines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 162. International Isotopes Therapeutic Nuclear Medicines Product Model Numbers, Pictures, Descriptions and Specifications

Table 163. International Isotopes Recent Developments

Table 164. Key Raw Materials Lists

Table 165. Raw Materials Key Suppliers Lists

Table 166. Therapeutic Nuclear Medicines Distributors List

Table 167. Therapeutic Nuclear Medicines Customers List

Table 168. Therapeutic Nuclear Medicines Market Trends

Table 169. Therapeutic Nuclear Medicines Market Drivers

Table 170. Therapeutic Nuclear Medicines Market Challenges

Table 171. Therapeutic Nuclear Medicines Market Restraints

Table 172. Research Programs/Design for This Report

Table 173. Key Data Information from Secondary Sources

Table 174. Key Data Information from Primary Sources

List of Figures

Figure 1. Therapeutic Nuclear Medicines Product Picture

Figure 2. Global Therapeutic Nuclear Medicines Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)

Figure 3. Global Therapeutic Nuclear Medicines Market Share by Type in 2023 & 2030

Figure 4. Radium-223 Product Picture

Figure 5. Lutetium-177 Product Picture

Figure 6. Iodine-131 Product Picture

Figure 7. Other Product Picture

Figure 8. Global Therapeutic Nuclear Medicines Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)

Figure 9. Global Therapeutic Nuclear Medicines Market Share by Application in 2023 & 2030

Figure 10. Thyroid

Figure 11. Bone Metastasis

Figure 12. Lymphoma

Figure 13. Other

Figure 14. Therapeutic Nuclear Medicines Report Years Considered

Figure 15. Global Therapeutic Nuclear Medicines Revenue, (US$ Million), 2019 VS 2023 VS 2030

Figure 16. Global Therapeutic Nuclear Medicines Revenue 2019-2030 (US$ Million)

Figure 17. Global Therapeutic Nuclear Medicines Revenue Market Share by Region in Percentage: 2023 Versus 2030

Figure 18. Global Therapeutic Nuclear Medicines Revenue Market Share by Region (2019-2030)

Figure 19. Global Therapeutic Nuclear Medicines Sales 2019-2030 ((K Units)

Figure 20. Global Therapeutic Nuclear Medicines Sales Market Share by Region (2019-2030)

Figure 21. US & Canada Therapeutic Nuclear Medicines Sales YoY (2019-2030) & (K Units)

Figure 22. US & Canada Therapeutic Nuclear Medicines Revenue YoY (2019-2030) & (US$ Million)

Figure 23. Europe Therapeutic Nuclear Medicines Sales YoY (2019-2030) & (K Units)

Figure 24. Europe Therapeutic Nuclear Medicines Revenue YoY (2019-2030) & (US$ Million)

Figure 25. China Therapeutic Nuclear Medicines Sales YoY (2019-2030) & (K Units)

Figure 26. China Therapeutic Nuclear Medicines Revenue YoY (2019-2030) & (US$ Million)

Figure 27. Asia (excluding China) Therapeutic Nuclear Medicines Sales YoY (2019-2030) & (K Units)

Figure 28. Asia (excluding China) Therapeutic Nuclear Medicines Revenue YoY (2019-2030) & (US$ Million)

Figure 29. Middle East, Africa and Latin America Therapeutic Nuclear Medicines Sales YoY (2019-2030) & (K Units)

Figure 30. Middle East, Africa and Latin America Therapeutic Nuclear Medicines Revenue YoY (2019-2030) & (US$ Million)

Figure 31. The Therapeutic Nuclear Medicines Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2023

Figure 32. The Top 5 and 10 Largest Manufacturers of Therapeutic Nuclear Medicines in the World: Market Share by Therapeutic Nuclear Medicines Revenue in 2023

Figure 33. Global Therapeutic Nuclear Medicines Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 34. Global Therapeutic Nuclear Medicines Sales Market Share by Type (2019-2030)

Figure 35. Global Therapeutic Nuclear Medicines Revenue Market Share by Type (2019-2030)

Figure 36. Global Therapeutic Nuclear Medicines Sales Market Share by Application (2019-2030)

Figure 37. Global Therapeutic Nuclear Medicines Revenue Market Share by Application (2019-2030)

Figure 38. US & Canada Therapeutic Nuclear Medicines Sales Market Share by Type (2019-2030)

Figure 39. US & Canada Therapeutic Nuclear Medicines Revenue Market Share by Type (2019-2030)

Figure 40. US & Canada Therapeutic Nuclear Medicines Sales Market Share by Application (2019-2030)

Figure 41. US & Canada Therapeutic Nuclear Medicines Revenue Market Share by Application (2019-2030)

Figure 42. US & Canada Therapeutic Nuclear Medicines Revenue Share by Country (2019-2030)

Figure 43. US & Canada Therapeutic Nuclear Medicines Sales Share by Country (2019-2030)

Figure 44. U.S. Therapeutic Nuclear Medicines Revenue (2019-2030) & (US$ Million)

Figure 45. Canada Therapeutic Nuclear Medicines Revenue (2019-2030) & (US$ Million)

Figure 46. Europe Therapeutic Nuclear Medicines Sales Market Share by Type (2019-2030)

Figure 47. Europe Therapeutic Nuclear Medicines Revenue Market Share by Type (2019-2030)

Figure 48. Europe Therapeutic Nuclear Medicines Sales Market Share by Application (2019-2030)

Figure 49. Europe Therapeutic Nuclear Medicines Revenue Market Share by Application (2019-2030)

Figure 50. Europe Therapeutic Nuclear Medicines Revenue Share by Country (2019-2030)

Figure 51. Europe Therapeutic Nuclear Medicines Sales Share by Country (2019-2030)

Figure 52. Germany Therapeutic Nuclear Medicines Revenue (2019-2030) & (US$ Million)

Figure 53. France Therapeutic Nuclear Medicines Revenue (2019-2030) & (US$ Million)

Figure 54. U.K. Therapeutic Nuclear Medicines Revenue (2019-2030) & (US$ Million)

Figure 55. Italy Therapeutic Nuclear Medicines Revenue (2019-2030) & (US$ Million)

Figure 56. Russia Therapeutic Nuclear Medicines Revenue (2019-2030) & (US$ Million)

Figure 57. China Therapeutic Nuclear Medicines Sales Market Share by Type (2019-2030)

Figure 58. China Therapeutic Nuclear Medicines Revenue Market Share by Type (2019-2030)

Figure 59. China Therapeutic Nuclear Medicines Sales Market Share by Application (2019-2030)

Figure 60. China Therapeutic Nuclear Medicines Revenue Market Share by Application (2019-2030)

Figure 61. Asia Therapeutic Nuclear Medicines Sales Market Share by Type (2019-2030)

Figure 62. Asia Therapeutic Nuclear Medicines Revenue Market Share by Type (2019-2030)

Figure 63. Asia Therapeutic Nuclear Medicines Sales Market Share by Application (2019-2030)

Figure 64. Asia Therapeutic Nuclear Medicines Revenue Market Share by Application (2019-2030)

Figure 65. Asia Therapeutic Nuclear Medicines Revenue Share by Region (2019-2030)

Figure 66. Asia Therapeutic Nuclear Medicines Sales Share by Region (2019-2030)

Figure 67. Japan Therapeutic Nuclear Medicines Revenue (2019-2030) & (US$ Million)

Figure 68. South Korea Therapeutic Nuclear Medicines Revenue (2019-2030) & (US$ Million)

Figure 69. China Taiwan Therapeutic Nuclear Medicines Revenue (2019-2030) & (US$ Million)

Figure 70. Southeast Asia Therapeutic Nuclear Medicines Revenue (2019-2030) & (US$ Million)

Figure 71. India Therapeutic Nuclear Medicines Revenue (2019-2030) & (US$ Million)

Figure 72. Middle East, Africa and Latin America Therapeutic Nuclear Medicines Sales Market Share by Type (2019-2030)

Figure 73. Middle East, Africa and Latin America Therapeutic Nuclear Medicines Revenue Market Share by Type (2019-2030)

Figure 74. Middle East, Africa and Latin America Therapeutic Nuclear Medicines Sales Market Share by Application (2019-2030)

Figure 75. Middle East, Africa and Latin America Therapeutic Nuclear Medicines Revenue Market Share by Application (2019-2030)

Figure 76. Middle East, Africa and Latin America Therapeutic Nuclear Medicines Revenue Share by Country (2019-2030)

Figure 77. Middle East, Africa and Latin America Therapeutic Nuclear Medicines Sales Share by Country (2019-2030)

Figure 78. Brazil Therapeutic Nuclear Medicines Revenue (2019-2030) & (US$ Million)

Figure 79. Mexico Therapeutic Nuclear Medicines Revenue (2019-2030) & (US$ Million)

Figure 80. Turkey Therapeutic Nuclear Medicines Revenue (2019-2030) & (US$ Million)

Figure 81. Israel Therapeutic Nuclear Medicines Revenue (2019-2030) & (US$ Million)

Figure 82. GCC Countries Therapeutic Nuclear Medicines Revenue (2019-2030) & (US$ Million)

Figure 83. Therapeutic Nuclear Medicines Value Chain

Figure 84. Therapeutic Nuclear Medicines Production Process

Figure 85. Channels of Distribution

Figure 86. Distributors Profiles

Figure 87. Bottom-up and Top-down Approaches for This Report

Figure 88. Data Triangulation

Figure 89. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

Global RANKL Inhibitors Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-35Z18485

Thu Dec 12 00:00:00 UTC 2024

Add to Cart

Morphine Test Kit - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages

Type: Report

Code: QYRE-Auto-28M18423

Thu Dec 12 00:00:00 UTC 2024

Add to Cart

Compound Antibacterial Agent for Animal - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages

Type: Report

Code: QYRE-Auto-38V14855

Thu Dec 12 00:00:00 UTC 2024

Add to Cart

Global Antipyretic Stickers Market Insights, Forecast to 2030

120 Pages

Type: Report

Code: QYRE-Auto-22E8302

Thu Dec 12 00:00:00 UTC 2024

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions